Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOLDEN-2: EP-101 in Moderate to Severe COPD
NCT01706536Phase 2Completed
- Sponsor
- Sunovion
- Start
- Oct 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycopyrrolate in chronic obstructive pulmonary disease (COPD), sponsored by Sunovion. Started Oct 2012; status: completed.
02
Drugs
glycopyrrolate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01706536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01706536.